FDA Adverse Event Malfunction Summary report: N

INTERA 3000

MDR report key: 22985472 · Received September 5, 2025

Report

Report Number
3015537318-2025-00081
Event Type
Malfunction
Date Received
September 5, 2025
Date of Event
August 11, 2025
Report Date
November 7, 2025
Manufacturer
INTERA ONCOLOGY, INC
Product Code
LKK
UDI-DI
00850014110147
PMA / PMN Number
P890055
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WV, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE HISTORY REVIEW WAS PERFORMED AND CONFIRMED THIS DEVICE MET MANUFACTURING SPECIFICATIONS PRIOR TO DISTRIBUTION AND THERE WERE NO MANUFACTURING DEVIATIONS THAT COULD HAVE CONTRIBUTED TO THE REPORTED EVENT. INTERA ONCOLOGY SENT OUT COMMUNICATIONS TO THE CLINIC MULTIPLE TIMES. AS OF TODAY, THE CLINIC HAS NOT RESPONDED TO OUR COMMUNICATIONS. THEREFORE, THE ROOT CAUSE OF THIS COMPLAINT REMAINS INCONCLUSIVE.

Additional Manufacturer Narrative · 0

A DEVICE HISTORY REVIEW WAS PERFORMED AND CONFIRMED THIS DEVICE MET MANUFACTURING SPECIFICATIONS PRIOR TO DISTRIBUTION AND THERE WERE NO MANUFACTURING DEVIATIONS THAT COULD HAVE CONTRIBUTED TO THE REPORTED EVENT. THE DEVICE REMAINS IMPLANTED AND IN USE. THEREFORE, THE ROOT CAUSE IS INCONCLUSIVE. AS PREVIOUSLY MENTIONED, THE PATIENT RESIDES IN A HIGH-ALTITUDE ZONE AND IS CONTINUING WITH TREATMENTS. THE INTERA 3000 HEPATIC ARTERY INFUSION PUMP INSTRUCTION FOR USE INDICATES THE PUMP FLOW RATE CAN VARY FOR A PATIENT THAT IS LIVING AT AN ELEVATION ABOVE SEA LEVEL.

Description of Event or Problem · 0

INTERA ONCOLOGY RECEIVED A CALL FROM A PHARMACIST SPECIALIST REGARDING A PATIENT'S PUMP RESIDUAL VOLUME DURING REFILL ON (B)(6) 2025. THE PATIENT DOES LIVE AT A HIGHER ALTITUDE, BUT HER FLOW RATE IS TYPICALLY 1.2-1.3 ML/DAY. THE PATIENT'S RESIDUAL VOLUME WAS 7 ML/DAY. THE PHARMACIST SPECIALIST WAS CONCERNED ABOUT THE PATIENT PUMP'S FLOW RATE. ON (B)(6) 2025, THE PATIENT WAS REFILLED WITH 30 ML OF HEPARIN, AND THE CLINIC WILL BRING THE PATIENT BACK IN AT THE END OF THE WEEK DUE TO CONCERNS OF THE PUMP FAST FLOWING. IF THE FLOW RATE HAS GONE BACK TO BASELINE, THEY WILL REFILL WITH FLOXURIDINE.

Description of Event or Problem · 0

INTERA ONCOLOGY RECEIVED A CALL FROM A PHARMACIST SPECIALIST REGARDING A PATIENT'S PUMP RESIDUAL VOLUME DURING REFILL ON (B)(6) 2025. THE PATIENT DOES LIVE AT A HIGHER ALTITUDE, BUT HER FLOW RATE IS TYPICALLY 1.2-1.3 ML/DAY. THE PATIENT'S RESIDUAL VOLUME WAS 7 ML/DAY. THE PHARMACIST SPECIALIST WAS CONCERNED ABOUT THE PATIENT PUMP'S FLOW RATE. ON (B)(6) 2025, THE PATIENT WAS REFILLED WITH 30 ML OF HEPARIN, AND THE CLINIC WILL BRING THE PATIENT BACK IN AT THE END OF THE WEEK DUE TO CONCERNS OF THE PUMP FAST FLOWING. IF THE FLOW RATE HAS GONE BACK TO BASELINE, THEY WILL REFILL WITH FLOXURIDINE. ON (B)(6) 2025, THE PHARMACIST RESPONDED TO OUR EMAIL. SHE PROVIDED INTERA ONCOLOGY WITH THE LAST FOUR REFILL RESULTS PRIOR TO (B)(6) 2025: ON (B)(6) 2025: 6.5 ML EXTRACTED, (B)(6) 2025: 8 ML EXTRACTED, (B)(6) 2025: 7 ML EXTRACTED, (B)(6) 2025: 7 ML EXTRACTED. THE PATIENT DID NOT EXPERIENCE AN ADVERSE REACTION. THE PUMP FLOW RATE FROM (B)(6) 2025, WAS 8 ML EXTRACTED: FLOW RATE = 1.57 ML/DAY. THE PATIENT HAS RESUME FLOXURIDINE TREATMENT, WITH AN ADJUSTED, PATIENT SPECIFIC FLOW RATE (1.6 ML/DAY).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
305018 INTERA 3000 HEPATIC ARTERY INFUSION PUMP LKK INTERA ONCOLOGY, INC AP-03000H 28538291 00850014110147

Patients

Seq Age Sex Outcome Treatment
1 60 YR Female